I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Zang, Aimin
105
results:
Search for persons
X
Format
Online (105)
Mediatypes
Articles (Online) (73)
Bookchapter (Online) (1)
OpenAccess-fulltext (31)
Sorted by: Relevance
Sorted by: Year
?
1
Regorafenib monotherapy or combined with an immune-checkpoi..:
Qu, Wang
;
Liu, Zimin
;
Chen, Xiaobing
...
BMC Cancer. 24 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
2
Patient-reported outcomes for the phase 3 FURLONG study of ..:
Shi, Yuankai
;
Chen, Gongyan
;
Wang, Xiang
...
The Lancet Regional Health - Western Pacific. 48 (2024) - p. 101122 , 2024
Link:
https://doi.org/10.1016/..
?
3
Efficacy and safety of MIL62, a novel glycoengineered type ..:
Shi, Yuankai
;
Zhou, Keshu
;
Zhou, Hui
...
eClinicalMedicine. 73 (2024) - p. 102702 , 2024
Link:
https://doi.org/10.1016/..
?
4
A phase Ib study evaluating the safety and efficacy of IBI3..:
Zhao, Yuguang
;
Chen, Xiao
;
Yao, Jun
...
Cancer Medicine. 13 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1002/..
?
5
Toripalimab plus nab-paclitaxel in metastatic or recurrent ..:
Jiang, Zefei
;
Ouyang, Quchang
;
Sun, Tao
...
Nature Medicine. 30 (2024) 1 - p. 249-256 , 2024
Link:
https://doi.org/10.1038/..
?
6
A pooled analysis of clinical outcome in driver-gene negati..:
Yu, Yongfeng
;
Dong, Wen
;
Shi, Yanxia
...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
7
Plasma proteome profiling reveals dynamic of cholesterol ma..:
Lyu, Jiacheng
;
Bai, Lin
;
Li, Yumiao
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
8
A global phase 3 study of serplulimab plus chemotherapy as ..:
Zhou, Caicun
;
Hu, Yanping
;
Arkania, Ekaterine
...
Cancer Cell. 42 (2024) 2 - p. 198-208.e3 , 2024
Link:
https://doi.org/10.1016/..
?
9
Gumarontinib in patients with non-small-cell lung cancer ha..:
Yu, Yongfeng
;
Zhou, Jianya
;
Li, Xingya
...
eClinicalMedicine. 59 (2023) - p. 101952 , 2023
Link:
https://doi.org/10.1016/..
?
10
First-in-human phase I/Ib study of QL1706 (PSB205), a bifun..:
Zhao, Yuanyuan
;
Ma, Yuxiang
;
Zang, Aimin
...
Journal of Hematology & Oncology. 16 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1186/..
?
11
Elevation of microRNA-365 impedes malignant behaviors of ga..:
Hong, Dan
;
Zang, Aimin
;
Wang, Zhiyu
...
Functional & Integrative Genomics. 22 (2022) 5 - p. 825-834 , 2022
Link:
https://doi.org/10.1007/..
?
12
Central Nervous System Efficacy of Furmonertinib (AST2818) ..:
Shi, Yuankai
;
Chen, Gongyan
;
Wang, Xiang
...
Journal of Thoracic Oncology. 17 (2022) 11 - p. 1297-1305 , 2022
Link:
https://doi.org/10.1016/..
?
13
Efficacy and Safety of Limertinib (ASK120067) in Patients W..:
Shi, Yuankai
;
Li, Baolan
;
Wu, Lin
...
Journal of Thoracic Oncology. 17 (2022) 10 - p. 1205-1215 , 2022
Link:
https://doi.org/10.1016/..
?
14
Phase 2 study of tislelizumab monotherapy in previously tre..:
Wang, Dong
;
Zhang, Naiyi
;
Zang, Aimin
...
Gynecologic Oncology. 166 (2022) - p. S80-S81 , 2022
Link:
https://doi.org/10.1016/..
?
15
Efficacy and safety of GLS-010 (zimberelimab) in patients w..:
Lin, Ningjing
;
Zhang, Mingzhi
;
Bai, Hai
...
European Journal of Cancer. 164 (2022) - p. 117-126 , 2022
Link:
https://doi.org/10.1016/..
1-15